172@29@17@101!~!172@29@0@53!~!|news|business|godfrey-phillips-cigarette-plant-located-in-navi-mumbai-resumes-production-5675191.html?utm_source=MC_OpeninApp!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false
Moneycontrol
FREE virtual training session on Passive Income Secrets: October 24 and 25, 2020, 10am to 1pm. Register Now!
you are here: HomeNewsBusiness
Last Updated : Aug 10, 2020 01:03 PM IST | Source: PTI

Godfrey Phillips' cigarette plant located in Navi Mumbai resumes production

The company had on March 30 informed the bourses about suspension of its manufacturing operations due to the lockdown on account of the coronavirus pandemic.

PTI
Representative Image
Representative Image
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Cigarettes and tobacco products major Godfrey Phillips India on Monday said its cigarette manufacturing plant located in Navi Mumbai, Maharashtra, has resumed manufacturing operations for export purposes after relaxation in lockdown guidelines.

The company had on March 30 informed the bourses about suspension of its manufacturing operations due to the lockdown on account of the coronavirus pandemic.

"Our plant at Rabale, Mumbai, has resumed manufacturing operations to produce for export purposes in accordance with the order issued by the government of Maharashtra for easing of restrictions," Godfrey Phillips India (GPI) said in a regulatory filing.

Close

In May, the company announced its wholly-owned arm International Tobacco Co had partially resumed manufacturing operations at Ghaziabad, Uttar Pradesh, plant. Later in June, Godfrey Phillips India's pan masala factory in Uttar Pradesh also resumed production.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
GPI manufactures cigarette brands, including Four Square, Red and White, Cavanders, Tipper and North Pole. It also manufactures and distributes Marlboro under a license agreement with Philip Morris.
First Published on Aug 10, 2020 12:55 pm
Sections